HealthEquity (HQY) Reports In-Line Q3 EPS, FY EPS Guidances Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Raymond James Downgrades HealthEquity, Inc (HQY) to Outperform
December 7, 2021 7:14 AM ESTRaymond James analyst C. Gregory Peters downgraded HealthEquity, Inc (NASDAQ: HQY) from Strong Buy to Outperform with a price target of $70.00 (from $90.00) following results.
The analyst commented, "The stock was down over 20% after hours last night as management lowered guidance (see page 2 for changes in guidance) for FY22 due in part to disappointing Service and Interchange revenue results. Service revenue declined 1.7% y/y to $103M in... More
